Detalhe da pesquisa
1.
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET).
Gut
; 72(8): 1581-1591, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788015
2.
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.
J Hepatol
; 72(4): 688-701, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31778751
3.
Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
J Hepatol
; 65(5): 899-905, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27388923
4.
Correction to 'Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF' [J Hepatol 2020 (72) 688-701].
J Hepatol
; 72(6): 1218-1220, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32192825
5.
Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis.
Liver Int
; 33(3): 398-409, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23402610
6.
Guidance document: risk assessment of patients with cirrhosis prior to elective non-hepatic surgery.
Frontline Gastroenterol
; 14(5): 359-370, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37581186
7.
A Double-Blind, Randomized Placebo-Controlled Trial of Probiotic Lactobacillus casei Shirota in Stable Cirrhotic Patients.
Nutrients
; 12(6)2020 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32498372